Multifaceted approach to the diagnosis and classification of acute leukemias

Clinical Chemistry

Volumn 46, Issue 8 II, 2000, Pages 1252-1259

  McKenna, R W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD14 ANTIGEN; CD36 ANTIGEN; CD64 ANTIGEN; CD71 ANTIGEN; FIBRINOGEN RECEPTOR; GLYCOPHORIN A; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CONFERENCE PAPER; CYTOGENETICS; CYTOLOGY; HUMAN; IMMUNOPHENOTYPING; LEUKEMOGENESIS; MOLECULAR BIOLOGY; PROGNOSIS;

EID: 0033897401     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.8.1252     Document Type: Conference Paper

References (42)

1. Acute leukemias
2. Morphologic and cytochemical characteristics of childhood lymphoblastic leukemia
3. Surface marker analysis of AML: Identification of differentiation-associated phenotypes
4. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia
5. Mixed lineage leukemia and asynchronous antigen expression
6. Biology and treatment of childhood T-lineage acute lymphoblastic leukemia
7. Childhood leukemias
8. Fifty years of studies of the biology and therapy of childhood leukemia
9. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia
10. Clinical significance of cytogenetics in acute myeloid leukemia
11. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia
12. Prognostic significance of chromosome abnormalities in acute leukaemias and myelodysplastic syndromes
13. Associations between morphology, karyotype and clinical features in myeloid leukemias
14. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: Results of MRC UKALL X
15. The molecular biology of myeloproliferative disorders as revealed by chromosomal abnormalities
16. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
17. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis
18. Current applications of molecular cytogenetic technologies
19. Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy
20. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome
21. Philadelphia positive acute lymphoblastic leukemia in adults. Age distribution BCR breakpoint and prognostic significance
22. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;23)
23. Translocation (9;22) is associated with extremely bad prognosis in intensively treated children with acute leukemia
24. MLL rearrangements in haematological malignancies
25. The pathogenesis of acute promyelocytic leukaemia: Evaluation of the role of molecular diagnosis and monitoring in the management of the disease
26. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia
27. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia
28. Cytologic characterization and significance of normal karyotypes in t(8;21) acute myeloblastic leukemia
29. AML1, the 8;21, 3;21 translocations in acute and chronic myeloid leukemia
30. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia
31. Molecular pathogenesis of the chromosome 16 inversion in the M4EO subtype of acute myeloid leukemia
32. Transcription factors, normal myeloid development, and leukemia
33. Lineage specificity in haematological neoplasms
34. Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance
35. Detection of minimal residual disease in acute myeloid leukaemia: Methodologies, clinical and biological significance
36. Proposals for the classification of the acute leukemias
37. Histological and cytological typing of neoplastic diseases of haematopoietic and lymphoid tissues
38. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the FAB Cooperative Group
39. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7)
40. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)
41. The morphological classification of acute lymphoblastic leukemia: Concordance among observers and clinical correlations
42. The World Health Organization classification of hematological malignancies